15.52
price up icon0.19%   0.03
after-market Dopo l'orario di chiusura: 15.52
loading
Precedente Chiudi:
$15.49
Aprire:
$15.53
Volume 24 ore:
1.19M
Relative Volume:
0.69
Capitalizzazione di mercato:
$1.86B
Reddito:
$59.61M
Utile/perdita netta:
$-262.14M
Rapporto P/E:
-3.9592
EPS:
-3.92
Flusso di cassa netto:
$-247.49M
1 W Prestazione:
-2.91%
1M Prestazione:
+3.54%
6M Prestazione:
+21.25%
1 anno Prestazione:
+41.09%
Intervallo 1D:
Value
$15.10
$15.59
Intervallo di 1 settimana:
Value
$15.10
$16.17
Portata 52W:
Value
$8.03
$17.75

Arcutis Biotherapeutics Inc Stock (ARQT) Company Profile

Name
Nome
Arcutis Biotherapeutics Inc
Name
Telefono
805-418-5006
Name
Indirizzo
3027 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA
Name
Dipendente
342
Name
Cinguettio
@ArcutisBio
Name
Prossima data di guadagno
2024-12-06
Name
Ultimi documenti SEC
Name
ARQT's Discussions on Twitter

Confronta ARQT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ARQT
Arcutis Biotherapeutics Inc
15.52 1.86B 59.61M -262.14M -247.49M -3.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.02 100.52B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.70 61.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
446.51 59.29B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
712.20 43.09B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
306.05 35.42B 3.81B -644.79M -669.77M -6.24

Arcutis Biotherapeutics Inc Stock (ARQT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-25 Iniziato Goldman Neutral
2024-12-30 Iniziato H.C. Wainwright Buy
2024-08-28 Iniziato Jefferies Buy
2024-01-03 Aggiornamento Mizuho Neutral → Buy
2023-10-26 Downgrade Mizuho Buy → Neutral
2023-10-13 Downgrade Goldman Buy → Neutral
2022-09-07 Iniziato Needham Buy
2022-03-17 Iniziato Goldman Buy
2021-06-30 Iniziato Mizuho Buy
2021-05-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-11-09 Aggiornamento Goldman Neutral → Buy
2020-10-08 Iniziato Truist Buy
2020-02-25 Iniziato Cantor Fitzgerald Overweight
2020-02-25 Iniziato Cowen Outperform
2020-02-25 Iniziato Goldman Neutral
2020-02-25 Iniziato Guggenheim Buy
Mostra tutto

Arcutis Biotherapeutics Inc Borsa (ARQT) Ultime notizie

pulisher
09:55 AM

Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 45.81% as Wall Street Analysts Expect? - au.finance.yahoo.com

09:55 AM
pulisher
06:05 AM

What’s the beta of Arcutis Biotherapeutics Inc. stockWeekly Investment Recap & AI Powered Market Entry Ideas - خودرو بانک

06:05 AM
pulisher
01:52 AM

Understanding Arcutis Biotherapeutics Inc.’s price movementChart Signals & Community Trade Idea Sharing Platform - Newser

01:52 AM
pulisher
12:05 PM

Trend Reversal Possible in Arcutis Biotherapeutics Inc. Charts Indicate getLinesFromResByArray error: size == 0 - thegnnews.com

12:05 PM
pulisher
Aug 31, 2025

What high frequency data says about Arcutis Biotherapeutics Inc.2025 Earnings Impact & High Conviction Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Combining machine learning predictions for Arcutis Biotherapeutics Inc.2025 AllTime Highs & Low Drawdown Investment Strategies - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can you recover from losses in Arcutis Biotherapeutics Inc.Quarterly Performance Summary & Community Trade Idea Sharing Platform - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Arcutis Biotherapeutics Inc. rebound enough to break evenMarket Rally & Risk Managed Investment Strategies - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Arcutis Biotherapeutics Inc. still worth holding after the dipPortfolio Update Report & Breakout Confirmation Trade Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Arcutis Biotherapeutics Inc. stock retracement – recovery analysis2025 EndofYear Setup & High Conviction Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 13:24:11 - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Arcutis Biotherapeutics Inc. continue its uptrendSwing Trade & Proven Capital Preservation Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Analysts Spot Bullish Divergence in Arcutis Biotherapeutics Inc. getLinesFromResByArray error: size == 0 - 클래시안

Aug 31, 2025
pulisher
Aug 31, 2025

Chart based analysis of Arcutis Biotherapeutics Inc. trendsLayoff News & Verified Momentum Stock Alerts - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Is Arcutis Biotherapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Movers & Daily Stock Trend Reports - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

What momentum shifts mean for Arcutis Biotherapeutics Inc.2025 Year in Review & Verified Chart Pattern Signals - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Tick level data insight on Arcutis Biotherapeutics Inc. volatility2025 Breakouts & Breakdowns & Verified Entry Point Detection - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Using RSI to spot recovery in Arcutis Biotherapeutics Inc.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Is Arcutis Biotherapeutics Inc. forming a bullish divergenceWeekly Trade Recap & Weekly High Momentum Picks - kpenews.com

Aug 29, 2025
pulisher
Aug 29, 2025

Applying big data sentiment scoring on Arcutis Biotherapeutics Inc.Day Trade & Expert Approved Trade Ideas - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Quant Strategy Flags Arcutis Biotherapeutics Inc. for Entry getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 29, 2025
pulisher
Aug 28, 2025

What’s next for Arcutis Biotherapeutics Inc. stock pricePortfolio Update Summary & Capital Efficiency Focused Strategies - Newser

Aug 28, 2025

Arcutis Biotherapeutics Inc Azioni (ARQT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Capitalizzazione:     |  Volume (24 ore):